Latest Series B Funding Rounds
Startups financing expansion after their early institutional rounds. Explore the businesses, round sizes and investors behind the next phase.
- Rounds
- 465 All time
- Disclosed funding
- $36.1B 412 disclosed amounts
- Median round
- $45.2M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| VA Vista AICompany profile Develops AI-powered MRI automation software for hospitals and imaging centers Develops AI-powered MRI automation software for hospitals and imaging centers | $29.5M | Series B | Healthtech | United States | Investors | |
| DU Defense UnicornsCompany profile Develops secure software delivery for national security mission systems Develops secure software delivery for national security mission systems | $136M | Series B | Defense tech | United States | Investors | |
| T3 The 33rd TeamCompany profile Provides football intelligence and technology for professional and collegiate teams Provides football intelligence and technology for professional and collegiate teams | Undisclosed | Series B | Consumer | United States | Investors | |
| J Develops commercial all-wing aircraft. | $175M | Series B | Mobility | United States | Investors | |
| V Provides stablecoin-powered financial infrastructure for global businesses | $20M | Series B | Fintech | United States | Investors | |
| MT Mirador TherapeuticsCompany profile Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases | $250M | Series B | Biotech | United States | Investors | |
| A AccelsiusCompany profile Two-phase liquid cooling for data centres running dense AI and high-performance computing workloads. Two-phase liquid cooling for data centres running dense AI and high-performance computing workloads. | $65M | Series B | Hardware | United States | Investors | |
| JT Develops regenerative biologics to restore tissue function | $33.5M | Series B | Biotech | United States | Investors | |
| KT Develops inhaled therapies for severe respiratory diseases | $103M | Series B | Biotech | United States | Investors | |
| A AbbelightCompany profile Microscopy and nanoscopy systems combining chemistry, optics and analysis for life-science researchers. Microscopy and nanoscopy systems combining chemistry, optics and analysis for life-science researchers. | Undisclosed | Series B | Biotech | France | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Y Combinator (YC)
Greptile, Nous Research, Firecrawl
19rounds0led - 2Andreessen Horowitz (a16z)
Town, Arena, Vesta
18rounds3led - 3Khosla Ventures
Even Healthcare, Arena, Vinci
18rounds3led - 4Accel
RapidCanvas, Armadin, Ema
14rounds1led - 5General Catalyst
Evvy, Faro AI, Senra Systems
14rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.